Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
False-positive reactions of some monoclonal anti-c reagents
Transfusion Medicine, 07/02/09
Strobel E et al. - Cross-reactivities of monoclonal reagents for red blood cell (RBC) typing are seen very rarely, e.g. in some reagents for testing of ABO or Lewis antigens. Some manufacturers give a remark on a possible cold agglutinin activity of their monoclonal anti-c reagents in the instruction leaflet, but in order to avoid such irritation, the authors recommend to remove this cross-reactivity by dilution during the manufacturing process.
Today in Transfusion Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Update on the use of deferasirox in the management of iron overload
Therapeutics and Clinical Risk Management, 11/05/09
Intravenous iron in inflammatory bowel disease
World Journal of Gastroenterology, 10/12/09
Duration of red blood cell storage is associated with increased incidence of deep vein thrombosis and in-hospital mortality in patients with traumatic injuries
Critical Care, 10/02/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


